• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泪腺黏膜相关淋巴组织淋巴瘤:根除幽门螺杆菌感染后持续缓解

Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland: sustained remission after eradication of helicobacter pylori infection.

作者信息

Hasosah Mohammed, Baothman Abdullah, Satti Mohamed, Kutbi Suzanne, Alghamdi Khaled, Jacobson Kevan

机构信息

Department of Pediatric Gastroenterology, King Saud Bin Abdulaziz University for Health Sciences/National Guard Health Affairs, P.O. Box 8202, Jeddah 21482, Saudi Arabia.

出版信息

Case Rep Gastrointest Med. 2011;2011:945752. doi: 10.1155/2011/945752. Epub 2011 Dec 7.

DOI:10.1155/2011/945752
PMID:22606434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3350112/
Abstract

Mucosa-associated lymphoid tissue (MALT) lymphoma is the third most common non-Hodgkin lymphoma, and it is strongly associated with helicobacter pylori infection of the stomach. MALT lymphoma of the lacrimal gland usually presents as a localized disease process in extranodal tissues. The treatment options of MALT lymphoma of the lacrimal gland chiefly include radiation of the tumor, chemotherapy, surgical removal, or a combination of these strategies. We report a case of localized MALT lymphoma of the lacrimal gland, with prolonged sustained remission after eradication of gastric Helicobacter pylori (H. Pylori) infection. He sustains in remission of lacrimal MALT lymphoma for four years without chemotherapy or radiotherapy.

摘要

黏膜相关淋巴组织(MALT)淋巴瘤是第三常见的非霍奇金淋巴瘤,它与胃部幽门螺杆菌感染密切相关。泪腺的MALT淋巴瘤通常表现为结外组织的局限性疾病过程。泪腺MALT淋巴瘤的治疗选择主要包括肿瘤放疗、化疗、手术切除或这些策略的联合应用。我们报告一例泪腺局限性MALT淋巴瘤病例,在根除胃部幽门螺杆菌(H. Pylori)感染后获得长期持续缓解。他在未进行化疗或放疗的情况下,泪腺MALT淋巴瘤已缓解四年。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32d/3350112/57190721332b/CRIM.GM2011-945752.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32d/3350112/09a652f4e9e8/CRIM.GM2011-945752.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32d/3350112/c4d60de1179e/CRIM.GM2011-945752.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32d/3350112/57190721332b/CRIM.GM2011-945752.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32d/3350112/09a652f4e9e8/CRIM.GM2011-945752.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32d/3350112/c4d60de1179e/CRIM.GM2011-945752.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32d/3350112/57190721332b/CRIM.GM2011-945752.003.jpg

相似文献

1
Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland: sustained remission after eradication of helicobacter pylori infection.泪腺黏膜相关淋巴组织淋巴瘤:根除幽门螺杆菌感染后持续缓解
Case Rep Gastrointest Med. 2011;2011:945752. doi: 10.1155/2011/945752. Epub 2011 Dec 7.
2
Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.幽门螺杆菌根除后胃黏膜相关淋巴组织低度恶性淋巴瘤的胃黏膜变化:48例随访研究
J Med Invest. 2000 Feb;47(1-2):36-46.
3
Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.胃黏膜相关淋巴组织淋巴瘤的治疗:幽门螺杆菌根除及其他。
Expert Rev Anticancer Ther. 2006 Mar;6(3):361-71. doi: 10.1586/14737140.6.3.361.
4
[Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].[幽门螺杆菌感染及根除治疗对胃黏膜相关淋巴组织淋巴瘤的预后影响]
Korean J Lab Med. 2010 Dec;30(6):547-53. doi: 10.3343/kjlm.2010.30.6.547.
5
Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.幽门螺杆菌根除治疗难治的胃黏膜相关淋巴组织淋巴瘤的放疗结果
Intern Med. 2006;45(6):405-9. doi: 10.2169/internalmedicine.45.1473. Epub 2006 Apr 17.
6
Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication.幽门螺杆菌根除后胃高级别黏膜相关淋巴组织(MALT)淋巴瘤的消退
Gut. 2001 Oct;49(4):584-7. doi: 10.1136/gut.49.4.584.
7
[Sustained Complete Remission after Eradication Therapy in A Helicobacter pylori-Negative Cecum Mucosa-Associated Lymphoid Tissue Lymphoma].[幽门螺杆菌阴性的盲肠黏膜相关淋巴组织淋巴瘤根除治疗后持续完全缓解]
Gan To Kagaku Ryoho. 2020 Oct;47(10):1513-1515.
8
Helicobacter suis infection is associated with nodular gastritis-like appearance of gastric mucosa-associated lymphoid tissue lymphoma.猪幽门螺杆菌感染与黏膜相关淋巴组织淋巴瘤的结节状胃炎样外观有关。
Cancer Med. 2019 Aug;8(9):4370-4379. doi: 10.1002/cam4.2314. Epub 2019 Jun 18.
9
Anti-Helicobacter pylori therapy in localized gastric mucosa-associated lymphoid tissue lymphoma: A prospective, nationwide, multicenter study in Japan.日本一项针对局限性胃黏膜相关淋巴组织淋巴瘤的抗幽门螺杆菌治疗的前瞻性、全国性、多中心研究。
Helicobacter. 2018 Apr;23(2):e12474. doi: 10.1111/hel.12474. Epub 2018 Mar 4.
10
[Helicobacter pylori eradication for stage I(E₁) gastric mucosa-associated lymphoid tissue lymphoma: predictive factors of complete remission].[幽门螺杆菌根除治疗Ⅰ期(E₁)胃黏膜相关淋巴组织淋巴瘤:完全缓解的预测因素]
Korean J Gastroenterol. 2010 Feb;55(2):94-9. doi: 10.4166/kjg.2010.55.2.94.

引用本文的文献

1
Marginal zone lymphoma of mucosa associated lymphoid tissue-lymphoma of the lacrimal gland in a young patient with Klinefelter syndrome: a case report.一名患有克兰费尔特综合征的年轻患者的黏膜相关淋巴组织边缘区淋巴瘤——泪腺淋巴瘤:病例报告
J Med Case Rep. 2024 Dec 26;18(1):640. doi: 10.1186/s13256-024-04996-0.
2
Stromal area differences with epithelial-mesenchymal transition gene changes in conjunctival and orbital mucosa-associated lymphoid tissue lymphoma.结膜和眼眶黏膜相关淋巴组织淋巴瘤中基质区域差异与上皮-间质转化基因变化
Front Oncol. 2024 Jan 23;14:1277749. doi: 10.3389/fonc.2024.1277749. eCollection 2024.
3

本文引用的文献

1
Ocular adnexal lymphoma and Helicobacter pylori gastric infection.眼附属器淋巴瘤与幽门螺杆菌胃部感染。
Am J Hematol. 2010 Sep;85(9):645-9. doi: 10.1002/ajh.21765.
2
The association between conjunctival MALT lymphoma and Helicobacter pylori.结膜黏膜相关淋巴组织淋巴瘤与幽门螺杆菌之间的关联。
Br J Ophthalmol. 2008 Apr;92(4):534-6. doi: 10.1136/bjo.2007.132316.
3
Assessment of the role of hepatitis C, Helicobacter pylori and autoimmunity in MALT lymphoma of the ocular adnexa in 45 Austrian patients.对45例奥地利患者眼附属器黏膜相关淋巴组织淋巴瘤中丙型肝炎、幽门螺杆菌及自身免疫作用的评估。
First-line antibiotic treatment in patients with localized extragastric mucosa-associated lymphoid tissue lymphoma.
局限性胃外黏膜相关淋巴组织淋巴瘤患者的一线抗生素治疗
EJHaem. 2022 Nov 6;4(1):55-66. doi: 10.1002/jha2.608. eCollection 2023 Feb.
4
Histochemical Comparison of Human and Rat Lacrimal Glands: Implications for Bio-Engineering Studies.人及大鼠泪腺组织化学比较:对生物工程研究的启示。
Transl Vis Sci Technol. 2022 Nov 1;11(11):10. doi: 10.1167/tvst.11.11.10.
5
Bilateral lacrimal gland lymphoma: Case report and literature review.双侧泪腺淋巴瘤:病例报告及文献综述
Radiol Case Rep. 2021 Nov 18;17(1):240-244. doi: 10.1016/j.radcr.2021.10.046. eCollection 2022 Jan.
Acta Oncol. 2008;47(3):355-9. doi: 10.1080/02841860701630283.
4
Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists.黏膜相关淋巴组织(MALT)淋巴瘤:病理学家实用指南
J Clin Pathol. 2007 Apr;60(4):361-72. doi: 10.1136/jcp.2005.031146. Epub 2006 Sep 1.
5
Bacteria-eradicating therapy for ocular adnexal MALT lymphoma: questions for an open international prospective trial.眼附属器黏膜相关淋巴组织淋巴瘤的细菌清除疗法:一项开放性国际前瞻性试验的问题
Ann Oncol. 2006 Nov;17(11):1721-2. doi: 10.1093/annonc/mdl124. Epub 2006 Jun 7.
6
Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation.源自边缘区B细胞的感染相关淋巴瘤:抗原驱动淋巴细胞增殖模型
Blood. 2006 Apr 15;107(8):3034-44. doi: 10.1182/blood-2005-09-3679. Epub 2006 Jan 5.
7
Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases.眼附属器边缘区B细胞淋巴瘤:23例临床与病理研究
Virchows Arch. 2006 Apr;448(4):506-16. doi: 10.1007/s00428-005-0122-0. Epub 2005 Dec 2.
8
MALT lymphoma in children: a report from the NHL-BFM Study Group.儿童黏膜相关淋巴组织淋巴瘤:来自NHL-BFM研究组的报告
Pediatr Blood Cancer. 2006 Aug;47(2):210-4. doi: 10.1002/pbc.20575.
9
MALT Lymphoma in Children: Case Report and Review of the Literature.儿童黏膜相关淋巴组织淋巴瘤:病例报告及文献综述
Pediatr Dev Pathol. 2004 Jul-Aug;7(4):407-13. doi: 10.1007/s10024-003-3025-6.
10
Are antibiotics the treatment of choice for gastric lymphoma?抗生素是胃淋巴瘤的首选治疗方法吗?
Curr Hematol Rep. 2004 Jan;3(1):11-6.